Related Experiment Videos
Mapping mutations in influenza A virus resistant to norakin
S Prösch1, H Heider, C Schroeder
1Institute of Virology, Humboldt University, School of Medicine (Charité), Berlin, GDR.
FEBS Letters
|July 2, 1990
Summary
Norakin resistance in influenza A virus stems from mutations in the hemagglutinin HA2 protein. These changes disrupt viral structure and function, impacting inhibitor efficacy.
Area of Science:
- Virology
- Structural Biology
- Drug Discovery
Background:
- Influenza A virus poses a significant global health threat.
- Understanding antiviral mechanisms is crucial for developing new treatments.
- Norakin is an inhibitor targeting influenza A virus.
Purpose of the Study:
- To investigate the molecular mechanisms by which norakin exerts its antiviral effect.
- To identify specific mutations conferring resistance to norakin.
- To elucidate the role of hemagglutinin structure in norakin's mode of action.
Main Methods:
- Sequencing of the hemagglutinin gene from 11 norakin-resistant influenza A virus mutants.
- Analysis of amino acid substitutions in relation to the 3D structure of hemagglutinin.
- Evaluation of the impact of mutations on protein structure and function.
Main Results:
- 11 norakin-resistant mutants exhibited 1-3 amino acid exchanges in the hemagglutinin gene.
- The majority of mutations were located in the HA2 polypeptide, altering charge or polarity.
- Mutations were observed to destabilize the hemagglutinin structure, affecting hydrogen bonds, salt-bridges, and fusion peptide localization.
Conclusions:
- Norakin's mechanism of action involves destabilizing the influenza A virus hemagglutinin structure.
- Amino acid substitutions in HA2 disrupt intra- and intersubunit contacts and fusion peptide stability.
- These structural alterations likely impede the virus's ability to infect host cells in the presence of norakin.